Topic: Vaccine Pricing

As the federal government stops purchasing COVID-19 vaccines in bulk, Pfizer and Moderna plan to raise prices to a range of $110 to $130 per dose on the open market. This represents a significant increase from the $26 per dose previously paid by the government. Jennifer Cates of the Kaiser Family Foundation notes that while insured individuals may not pay out-of-pocket, the costs will likely lead to higher insurance premiums.

Claims are discussed regarding the renaming of polio symptoms to Guillain-Barre syndrome in cases where vaccines fail to provide immunity. The discussion also covers the high cost of the HPV vaccine, which can reach $800 for a two-shot series. The hosts describe a "sales cycle" where doctors use inconclusive pap smear results to pressure women into purchasing expensive and potentially unnecessary vaccinations.